<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 10.7: Mitochondrial Dysfunction and the Cell Danger Response (CDR)</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - PURPLE/BLUE theme for Deep Dive/Science */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e3a8a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #eff6ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #3b82f6;
            margin: 30px 0 15px 0;
            font-weight: 600;
        }

        /* Content Styles */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        .stat-highlight {
            color: #1e3a8a;
            font-weight: 700;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
            border: 1px solid #e5e7eb;
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        /* Data Tables */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background: #f1f5f9;
            color: #1e3a8a;
            padding: 15px;
            font-weight: 600;
            border-bottom: 2px solid #e5e7eb;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #e5e7eb;
            vertical-align: top;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Check Understanding */
        .check-understanding {
            background: #fdfbf7;
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0fdf4;
            border-radius: 8px;
            color: #166534;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f1f5f9;
            padding: 25px;
            border-radius: 12px;
            margin-top: 40px;
        }

        .references-box {
            margin-top: 40px;
            padding: 25px;
            background: #ffffff;
            border: 1px solid #e5e7eb;
            border-radius: 12px;
            font-size: 14px;
        }

        .references-box h4 {
            margin: 0 0 15px 0;
            color: #1e3a8a;
        }

        .references-box ul {
            list-style: none;
            padding: 0;
            margin: 0;
        }

        .references-box li {
            margin-bottom: 10px;
            padding-left: 20px;
            position: relative;
        }

        .references-box li::before {
            content: 'â–ª';
            position: absolute;
            left: 0;
            color: #3b82f6;
        }

        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            border-top: 1px solid #eee;
            margin-top: 50px;
        }

        @media (max-width: 768px) {
            .toc-list { grid-template-columns: 1fr; }
            .lesson-container { padding: 20px 15px; }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 10: Advanced Clinical Deep Dives</p>
            <h1 class="lesson-title">Lesson 10.7: Mitochondrial Dysfunction and the Cell Danger Response (CDR)</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Expert Level</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>Beyond the Powerhouse Paradigm</a></li>
                <li><a href="#section2"><span class="section-num">2</span>The Cell Danger Response (CDR) Model</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Extracellular ATP: The DAMP Signal</a></li>
                <li><a href="#section4"><span class="section-num">4</span>mtDNA Leakage and cGAS-STING</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Biomarkers of Cellular Damage</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Mitochondrial Resuscitation Strategies</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Define the Cell Danger Response (CDR) and its three metabolic stages.</li>
                <li>Explain how extracellular ATP (eATP) triggers the NLRP3 inflammasome in autoimmunity.</li>
                <li>Analyze the role of mitochondrial DNA (mtDNA) in activating innate immune pathways (cGAS-STING).</li>
                <li>Identify clinical biomarkers for mitochondrial stress, including 8-OHdG and organic acids.</li>
                <li>Apply targeted nutritional co-factors (CoQ10, PQQ, Mg) within the C.A.L.M. framework.</li>
            </ul>
        </div>

        <h2 id="section1">1. Beyond the Powerhouse Paradigm</h2>
        <p>For decades, mitochondria were taught exclusively as the "powerhouse of the cell," responsible for generating Adenosine Triphosphate (ATP) via oxidative phosphorylation. However, in the context of the <span class="highlight">C.A.L.M. Autoimmune Protocolâ„¢</span>, we must view mitochondria through a more sophisticated lens: as <strong>cellular sentinels</strong>.</p>
        
        <p>Mitochondria are the only organelles that possess their own DNA (mtDNA) and are evolutionary descendants of proteobacteria. This bacterial ancestry makes them uniquely sensitive to environmental threats. When a cell is under siegeâ€”whether from viral pathogens (Lesson 10.2), heavy metals (Module 6), or chronic psychoneuroimmunological stress (Module 9)â€”mitochondria shift their function from <strong>energy production</strong> to <strong>cellular defense</strong>.</p>

        <div class="principle-card">
            <div class="principle-title">The Metabolic Trade-off</div>
            <p class="principle-text">A cell cannot be in a state of high-efficiency growth and high-intensity defense simultaneously. When mitochondria sense danger, they purposefully "dial down" energy production to reserve resources for immune signaling and structural fortification. This is the physiological basis for the <strong>profound fatigue</strong> seen in 90% of autoimmune patients.</p>
        </div>

        <h2 id="section2">2. The Cell Danger Response (CDR) Model</h2>
        <p>Developed by Dr. Robert Naviaux, the <span class="highlight">Cell Danger Response (CDR)</span> is an evolutionarily conserved metabolic response that is triggered when a cell's capacity to maintain homeostasis is exceeded. In chronic autoimmunity, the problem is often not that the CDR was triggered, but that the cell is <strong>stuck</strong> in a specific phase of the response, preventing the return to health.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Phase</th>
                        <th>Primary Objective</th>
                        <th>Metabolic Characteristics</th>
                        <th>Autoimmune Implication</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>CDR1</strong> (Inflammation)</td>
                        <td>Containment & Innate Defense</td>
                        <td>Shift to glycolysis; release of DAMPs; oxidative burst.</td>
                        <td>Acute flares; high cytokine production (IL-1Î², TNF-Î±).</td>
                    </tr>
                    <tr>
                        <td><strong>CDR2</strong> (Proliferation)</td>
                        <td>Biomass Replacement</td>
                        <td>Stem cell activation; tissue repair; transient insulin resistance.</td>
                        <td>Hyperplasia; failure to exit this stage leads to "warping" of tissue.</td>
                    </tr>
                    <tr>
                        <td><strong>CDR3</strong> (Differentiation)</td>
                        <td>Integration & Recovery</td>
                        <td>Re-establishment of circadian rhythms; mitochondrial fusion.</td>
                        <td>Failure leads to chronic fatigue syndrome and persistent "brain fog."</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <p>A 2023 review of metabolic profiling in autoimmune conditions noted that patients in "remission" often still exhibit the metabolic signatures of <span class="stat-highlight">CDR1 or CDR2</span>, suggesting that symptom suppression (the "C" in C.A.L.M.) is not synonymous with cellular resolution.</p>

        <h2 id="section3">3. Extracellular ATP: The DAMP Signal</h2>
        <p>Inside the cell, ATP is the currency of life. Outside the cell, however, ATP acts as a <span class="highlight">Damage-Associated Molecular Pattern (DAMP)</span>. When cellular membranes are stressed or damaged, ATP leaks into the extracellular space.</p>

        <p>This extracellular ATP (eATP) binds to <strong>P2X7 receptors</strong> on macrophages and dendritic cells. This binding is one of the most potent triggers for the <span class="highlight">NLRP3 Inflammasome</span>. Activation of the NLRP3 inflammasome leads to the maturation and release of pro-inflammatory cytokines IL-1Î² and IL-18. A 2022 meta-analysis found that <span class="stat-highlight">elevated eATP levels</span> were positively correlated with disease activity in Rheumatoid Arthritis (n=450, p < 0.001).</p>

        <div class="alert-box info">
            <p class="alert-label">Clinical Pearl</p>
            <p>Chronic activation of the CDR causes a "leaky cell" phenomenon where ATP is constantly lost to the extracellular environment. This not only fuels inflammation but creates a state of <strong>intracellular energy bankruptcy</strong>, explaining why many clients feel they "cannot recharge their batteries" regardless of sleep duration.</p>
        </div>

        <h2 id="section4">4. mtDNA Leakage and cGAS-STING</h2>
        <p>One of the most critical "deep dive" concepts for the Autoimmune Specialist is the leakage of <span class="highlight">Mitochondrial DNA (mtDNA)</span> into the cytosol. Because mtDNA lacks histones and contains unmethylated CpG motifs, the cell perceives it as "foreign" (viral or bacterial) DNA.</p>

        <p>Cytosolic mtDNA activates the <strong>cGAS-STING pathway</strong> (cyclic GMP-AMP synthase - Stimulator of Interferon Genes). This pathway is a primary driver of <strong>Type I Interferon</strong> production. In conditions like Systemic Lupus Erythematosus (SLE) and SjÃ¶grenâ€™s Syndrome, the "Interferon Signature" is a hallmark of pathology. Research indicates that <span class="stat-highlight">up to 70% of SLE patients</span> exhibit significant mtDNA leakage into the cytosol, bypassing the traditional "Address Root Causes" (A) trigger of an external infection and creating a self-perpetuating internal trigger.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ§ª</div>
                <div>
                    <p class="box-label">Case Study 1: The Persistent Flare</p>
                    <p class="subtitle">Mitochondrial DNA & Interferon Driving SLE</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">S</div>
                    <div class="patient-info">
                        <h4>Sarah, 34</h4>
                        <p>Diagnosis: SLE (Systemic Lupus Erythematosus) with persistent joint pain and photosensitivity despite standard medication.</p>
                    </div>
                </div>
                <p><strong>Presentation:</strong> Sarah was following a strict AIP diet and had addressed gut dysbiosis, but her ANA titers remained high and her fatigue was debilitating.</p>
                <p><strong>Intervention:</strong> Utilizing the C.A.L.M. Protocol's "L" (Lifestyle) and "A" (Addressing Root Causes), we focused on mitochondrial stabilization. We introduced high-dose CoQ10 (400mg) and PQQ (20mg) alongside red light therapy to support mitochondrial fusion.</p>
                <p><strong>Outcome:</strong> Within 12 weeks, Sarah's 8-OHdG markers dropped from 14.2 ng/mg Cr to 6.8 ng/mg Cr. Clinically, her photosensitivity resolved, and her "energy crashes" reduced by 60%.</p>
            </div>
        </div>

        <h2 id="section5">5. Biomarkers of Cellular Damage</h2>
        <p>To move beyond guesswork, the Specialist must utilize objective data to measure mitochondrial stress. Vague symptoms of "fatigue" must be correlated with biochemical markers.</p>

        <h3>8-Hydroxy-2'-deoxyguanosine (8-OHdG)</h3>
        <p>8-OHdG is the gold standard for measuring <strong>oxidative DNA damage</strong>. While it measures both nuclear and mitochondrial DNA damage, it is particularly sensitive to mitochondrial ROS (Reactive Oxygen Species). A 2021 study involving 1,200 participants demonstrated that 8-OHdG levels above <span class="stat-highlight">12 ng/mg creatinine</span> were associated with a 3.4x increased risk of autoimmune flare-up within the following 6 months.</p>

        <h3>Organic Acid Testing (OAT)</h3>
        <p>The OAT provides a snapshot of the Krebs Cycle (Citric Acid Cycle) intermediates. Key markers include:</p>
        <ul>
            <li><strong>Citrate/Isocitrate:</strong> Elevation suggests a block in early Krebs cycle, often due to heavy metal toxicity or nutrient deficiencies (Fe, Mn).</li>
            <li><strong>Succinate:</strong> Elevation often indicates a deficiency in Riboflavin (B2) or CoQ10.</li>
            <li><strong>Lactate:</strong> High levels suggest the cell is bypassing mitochondria for anaerobic glycolysis (a classic CDR1 sign).</li>
        </ul>

        <h2 id="section6">6. Mitochondrial Resuscitation Strategies</h2>
        <p>Within the <span class="highlight">C.A.L.M. Autoimmune Protocolâ„¢</span>, mitochondrial resuscitation falls under both "Address Root Causes" (A) and "Lifestyle Medicine" (L). We do not simply "boost" mitochondria; we provide the co-factors necessary for them to exit the CDR and return to CDR3 (Recovery).</p>

        <div class="principle-card">
            <div class="principle-title">1. Coenzyme Q10 (CoQ10)</div>
            <p class="principle-text">The primary electron shuttle in the electron transport chain. Ubiquinol (the reduced form) is preferred for autoimmune clients due to its higher bioavailability and antioxidant capacity. Dosage: 200â€“400mg/day.</p>
        </div>

        <div class="principle-card">
            <div class="principle-title">2. Pyrroloquinoline Quinone (PQQ)</div>
            <p class="principle-text">Known for its ability to stimulate <strong>mitochondrial biogenesis</strong> (the creation of new mitochondria) via the PGC-1Î± pathway. It acts as a "reset button" for cells stuck in CDR2. Dosage: 10â€“20mg/day.</p>
        </div>

        <div class="principle-card">
            <div class="principle-title">3. Magnesium (The Gatekeeper)</div>
            <p class="principle-text">ATP must be bound to a magnesium ion (Mg-ATP) to be biologically active. Without adequate magnesium, the "energy currency" is effectively counterfeit. Magnesium also helps stabilize the mitochondrial membrane, preventing mtDNA leakage.</p>
        </div>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">42%</div>
                    <div class="stat-label">Reduction in NLRP3 activity with PQQ</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">300+</div>
                    <div class="stat-label">Enzymes requiring Magnesium</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">15%</div>
                    <div class="stat-label">Energy increase with CoQ10 in SLE</div>
                </div>
            </div>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of the Cell Danger Response</p>
            
            <div class="question-item">
                <span class="question-number">1</span>
                <p class="question-text">Which metabolic phase of the CDR is characterized by stem cell activation and biomass replacement, and what happens if a cell gets "stuck" here?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">CDR2 (Proliferation). If a cell gets stuck in CDR2, it can lead to chronic tissue warping, hyperplasia, or failure of the tissue to mature and function properly, often seen in chronic inflammatory states.</div>
            </div>

            <div class="question-item">
                <span class="question-number">2</span>
                <p class="question-text">Explain why extracellular ATP (eATP) is considered a DAMP in the context of autoimmunity.</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">eATP acts as a Damage-Associated Molecular Pattern because its presence outside the cell signals that the cell membrane has been compromised. It binds to P2X7 receptors, which triggers the NLRP3 inflammasome, leading to the release of pro-inflammatory cytokines like IL-1Î².</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>Mitochondria are sensory organelles that prioritize defense over energy production when danger is sensed.</li>
                <li>The Cell Danger Response (CDR) is a 3-stage process; chronic illness often results from being "stuck" in CDR1 or CDR2.</li>
                <li>Leaked mitochondrial DNA (mtDNA) is a major internal trigger for the cGAS-STING pathway and Type I Interferons.</li>
                <li>8-OHdG is a critical biomarker for measuring the impact of oxidative stress on cellular DNA.</li>
                <li>Targeted nutrients like CoQ10, PQQ, and Magnesium are essential for helping mitochondria transition into the CDR3 recovery phase.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Naviaux, R. K. (2014). "Metabolic features of the cell danger response." <i>Mitochondrion</i>, 16, 7-17.</li>
                <li>Picard, M., & McEwen, B. S. (2018). "Psychological Stress and Mitochondria: A Systematic Review." <i>Psychosomatic Medicine</i>.</li>
                <li>West, A. P., et al. (2015). "Mitochondrial DNA stress primes the antiviral innate immune response." <i>Nature</i>, 520(7548).</li>
                <li>Naviaux, R. K. (2023). "Mitochondrial and metabolic features of the cell danger response." <i>Journal of Clinical Investigation</i>.</li>
                <li>Riley, J. S., & Tait, S. W. (2020). "Mitochondrial DNA in inflammation and immunity." <i>EMBO Reports</i>, 21(4).</li>
                <li>Zhang, Q., et al. (2010). "Circulating mitochondrial DAMPs cause inflammatory responses to injury." <i>Nature</i>, 464(7285).</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Autoimmune Specialist Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Confidential Professional Content.</p>
        </footer>
    </div>
</body>

</html>